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Redox and Nitric Oxide-Mediated Regulation
of Sensory Neuron Ion Channel Function
Nikita Gamper1 and Lezanne Ooi2
Abstract
Significance: Reactive oxygen and nitrogen species (ROS and RNS, respectively) can intimately control
neuronal excitability and synaptic strength by regulating the function of many ion channels. In peripheral
sensory neurons, such regulation contributes towards the control of somatosensory processing; therefore, un-
derstanding the mechanisms of such regulation is necessary for the development of new therapeutic strategies
and for the treatment of sensory dysfunctions, such as chronic pain. Recent Advances: Tremendous progress in
deciphering nitric oxide (NO) and ROS signaling in the nervous system has been made in recent decades. This
includes the recognition of these molecules as important second messengers and the elucidation of their
metabolic pathways and cellular targets. Mounting evidence suggests that these targets include many ion
channels which can be directly or indirectly modulated by ROS and NO. However, the mechanisms specific to
sensory neurons are still poorly understood. This review will therefore summarize recent findings that highlight
the complex nature of the signaling pathways involved in redox/NO regulation of sensory neuron ion channels
and excitability; references to redox mechanisms described in other neuron types will be made where necessary.
Critical Issues: The complexity and interplay within the redox, NO, and other gasotransmitter modulation of
protein function are still largely unresolved. Issues of specificity and intracellular localization of these signaling
cascades will also be addressed. Future Directions: Since our understanding of ROS and RNS signaling in
sensory neurons is limited, there is a multitude of future directions; one of the most important issues for further
study is the establishment of the exact roles that these signaling pathways play in pain processing and the
translation of this understanding into new therapeutics. Antioxid. Redox Signal. 22, 486–504.
Introduction
The mammalian peripheral somatosensory systemcomprises sensory fibers that innervate tissues such as
skin, muscles, and viscera. These fibers sense thermal, che-
mical, tactile, and damage-related (‘‘pain’’) stimuli within
the periphery and convey this information to the central
nervous system (CNS). The fibers themselves are composed
of the axons of peripheral sensory neurons whose cell bodies
reside within peripheral ganglia (such as dorsal root ganglia
[DRG], trigeminal ganglia [TG], or nodose ganglia). The
distal ends of these axons form nerve endings within the
innervated organs (i.e., skin), whereas the proximal ends
synapse in the spinal cord. Peripheral sensory neurons, along
with motor neurons, represent some of the longest cells
within our bodies, in some cases extending axons beyond 1 m
in humans (Fig. 1) and can be even longer in larger mammals.
The stimulus-induced generation of action potentials within
the peripheral terminals of sensory nerves and the subsequent
propagation of these action potentials toward the first synapse
in the spinal cord constitute peripheral somatosensory
transmission. This process is mediated by the concerted ac-
tion of sensory fiber plasmalemmal ion channels. The path-
ological deregulation of these ion channels can disturb
somatosensory transmission and can result in pathological
pain, which is increasingly viewed as a group of ion channel-
related disorders or ‘‘channelopathies’’ (144). Not surpris-
ingly, the regulation and modulation of peripheral sensory
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neuron ion channels, particularly in relation to pain, is a sub-
ject of intense research [see recent reviews (49, 93, 134, 144)].
Reactive oxygen species (ROS), nitric oxide (NO), and other
modulators derived from soluble gaseous molecules are in-
creasingly being recognized for their roles as intracellular
second messengers and, among others, as potent regulators of
ion channel activity [see, e.g., Wang (209)]. The field is,
however, still in its early years and the regulation of sensory
neuron excitability by ROS, NO, and gasotransmitters is a
topic that we still know very little about. The aim of this article
is to summarize and categorize current knowledge in this area.
Mechanisms of ROS Generation
Molecular mechanisms of ROS metabolism are well
studied in the brain with much less literature focused spe-
cifically on the peripheral nervous system. Although such
mechanisms may differ between neuron types, the key steps
of ROS metabolism are similar. One of the major ROS spe-
cies in cells is the superoxide anion (O2
 - ), which is gener-
ated by one-electron reduction of O2. In mitochondria, this
mainly happens at electron transport chain (ETC) complexes
I and III [Fig. 2; reviewed in Murphy (118)], a-ketoglutarate
dehydrogenase (175, 199), a-glycerophosphate dehydrogenase
(200), and some other ETC sites. Outside of the mitochon-
dria, O2
 - can be produced by xanthine oxidase-catalyzed
hypoxanthine oxidation (81), plasma membrane NADPH
oxidase (87), as well as by the phospholipase A2-dependent
cyclo-oxygenases and lipoxygenases (33). The O2
 - is highly
reactive and can oxidize many moieties; however, it is usually
rapidly converted to hydrogen peroxide (H2O2) in a dismuta-
tion reaction catalyzed by the enzyme superoxide dismutase
[i.e., mitochondrial manganese SOD (MnSOD) or cytosolic
copper/zinc SOD (Cu/ZnSOD)] (Fig. 2) (143). H2O2 is also a
potent oxidizer and it can be involved in further reactions and
produce several other ROS, including the highly reactive hy-
droxyl radical (OH) (in a Fenton reaction with Fe2 + ) (140).
Mechanisms of NO Generation
The metabolism of nitrosyl species is tightly linked with
oxygen and ROS. Synthesis of NO and l-citrulline by nitric
oxide synthases (NOS) occurs via a two-step conversion
process involving molecular oxygen (O2), l-arginine and
nicotinamide adenine dinucleotide phosphate (NADPH), as
co-substrates. The reaction also involves the prosthetic
groups calmodulin and haem, with flavin adenine dinu-
cleotide (FAD), flavin mononucleotide (FMN), and tetra-
hydrobiopterin (BH4) as co-factors (5) (Fig. 3). There are
three isoforms of NOS in mammalian systems encoded by
separate genes; two of these are termed constitutive enzymes
(cNOS), encompassing neuronal NOS (nNOS, encoded by the
NOS1 gene) and endothelial NOS (eNOS, encoded by NOS3).
These enzymes are activated by a Ca2 + /calmodulin complex,
which distinguishes them from inducible NOS (iNOS, en-
coded by NOS2) that is Ca2 + independent and activated by
inflammatory stimulation. All three isoforms of NOS can be
found in the central and peripheral nervous systems. Cytosolic
nNOS is expressed in neurons across a diverse range of loca-
tions, including the hippocampus and neocortex; membrane-
bound eNOS is expressed in endothelial cells as well as neurons;
and iNOS is expressed in astrocytes and microglia. In the pe-
ripheral somatosensory system, nNOS was detected in small-
and medium-sized DRG neurons of various mammals, and it
was colocalized with some nociceptive neuron markers, in-
cluding calcitonin gene-related peptide (CGRP), substance P,
and TRPV1 (24, 108, 116, 141, 177, 193, 203, 227). NOS
expression was also reported in small- and medium-sized TG
neurons (83, 88, 183).
Interplay Between NO and ROS
The reversible binding of Ca2 + to calmodulin is the pri-
mary controller of cNOS activity, with increases in free cy-
tosolic Ca2 + initiating the production of NO [reviewed in
FIG. 1. Simplified anatomy of the peripheral somato-
sensory system. (A) Sensory fibers within the peripheral
somatosensory system detect thermal, chemical, tactile, and
damage-related (nociceptive) stimuli within skin, viscera,
muscles, etc., and convey this information to the spinal cord.
The fibers are composed of the axons of peripheral sensory
neurons whose cell bodies reside within peripheral ganglia
(such as DRG, TG, or nodose ganglia). The axons form
nerve endings with peripheral organs and synapses in the
spinal cord. (B) Peripheral sensory neurons represent some
of the longest cells within our bodies. The relative size of a
cell body compared with the axon of a DRG neuron inner-
vating hindlimb skin in humans is illustrated; adapted from
Devor (43) with permission. DRG, dorsal root ganglia; TG,
trigeminal ganglia.
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FIG. 2. Schematic representation of ROS generation in mitochondria. The main sites of ROS generation within
mitochondrial ETC are ETC complexes I and III (complexes I to V are represented by gray shapes and labeled accordingly).
O2
 - is formed by molecular oxygen reacting with the electrons from the ETC. In the mitochondrial matrix, O2
 - is
converted to H2O2 by MnSOD. H2O2 can then be reduced to H2O and O2 by catalase or through glutathione/thioredoxin
reduction pathways. In the intermembrane space of mitochondria, O2
 - can be generated at complex III, where it is reduced
to H2O2 by CuSOD and ZnSOD. Based on the generalizations provided in Refs. (118, 196). IMM, inner mitochondrial
membrane; GR, gluthathione reductase; GS, glutathione synthase; TR, thioredoxin; ETC, electron transport chain; MnSOD,
manganese superoxide dismutase; CuSOD, copper superoxide dismutase; ZnSOD, zinc superoxide dismutase; ROS, re-
active oxygen species; H2O2, hydrogen peroxide; O2
 - , superoxide anion.
FIG. 3. Catalytic action of cNOS. The binding of Ca2 + to calmodulin enables the flow of electrons through the reductase
domain of cNOS. NADPH donates an electron (e - ) to the reductase domain of cNOS, proceeding via FAD and FMN redox
carriers to the oxgyenase domain. The e - interacts with haem iron and BH4 at the active site to catalyze the reaction of O2
with l-arginine, generating NO and l-citrulline as products. Low concentrations of the substrates or co-factors result in the
uncoupling of cNOS with the e - passed to O2, resulting in cNOS generating O2
 - in addition to NO. The O2
 - and NO can
readily react and produce ONOO - , a powerful oxidant. The uncoupled pathway leading to nitrosative stress is indicated by
the gray arrows. cNOS, constitutive nitric oxide synthase; NADPH, nicotinamide adenine dinucleotide phosphate; FAD,
flavin adenine dinucleotide; FMN, flavin mononucleotide; O2, oxygen; NO, nitric oxide; ONOO
-, peroxynitrite anion;
BH4, tetrahydrobiopterin.
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Schmidt et al. (162)]. Inhibition of cNOS is triggered through
negative feedback of NO on the enzyme in a concentration-
dependent manner. For cNOS to exclusively produce NO and
l-citrulline, high concentrations of the substrates and cofac-
tors should be present to ensure that the dimeric structure
of the enzyme remains coupled. Low concentrations of any
of the earlier components results in a one-electron transfer
from the reductase domain of uncoupled NOS to O2, resulting
in the generation of O2
 - in addition to NO. NO can then
react with O2
 - and produce peroxynitrite anion (ONOO - ),
a powerful oxidant and cytotoxic agent (215). At low con-
centrations, ONOO - easily isomerizes into the harmless ni-
trate ion; however when produced at high concentrations,
ONOO - may undergo symmetrical or non-symmetrical
cleavage and form nitrogen dioxide (NO2), carbonate
(CO3
 - ), and OH radicals, all of which are considered more
reactive and toxic than NO (Fig. 4) (109). Within membranes,
NO2 is also formed from auto-oxidation of NO (101). These
downstream products are more aggressive oxidants than the
parent molecules, with the potential ability to induce exten-
sive inflammation and neuronal death.
ROS and the Peripheral Somatosensory System
Increased ROS generation is implicated in several patho-
logical conditions related to pain; these include inflammation
[i.e., chronic pancreatitis (190)] and diabetes mellitus. Dia-
betes is often accompanied by the peripheral neuropathies
(diabetic neuropathy), and oxidative stress is a widely ac-
cepted key factor in its development (53). The incidence of
neuropathy in diabetic patients can be very high (up to 50%);
the major feature of this syndrome is sensory and motor fiber
degeneration, with longer axons being the most affected.
Diabetic neuropathy is an incapacitating condition accom-
panied by pain, foot ulceration, digestive abnormalities,
sensory loss, erectile dysfunction, and heart arrhythmias
among other conditions. In both type 1 and type 2 diabetes,
there is significant accumulation of extracellular glucose,
which is transported into the cytosol of cells faster than en-
dogenous metabolic pathways can accommodate it (167).
Under these conditions, glucose enters an alternative meta-
bolic pathway where it is converted to sorbitol by the enzyme
aldose reductase (112). This reaction requires NADPH,
which, in turn, becomes less available for the production of
the intracellular antioxidant glutathione from glutathione
disulfide by the NADPH-dependent enzyme glutathione re-
ductase. Reduced glutathione levels, in turn, make cells
highly vulnerable to ROS (112, 201). Hyperglycemia may
cause redox disturbances in a number of additional ways.
Glucose can undergo auto-oxidation in the presence of trace
amounts of free transition metals, yielding a-ketoaldehydes,
H2O2 and ROS (213). Thus, reduced antioxidant capacity in
combination with increased ROS production creates a cel-
lular background for oxidative stress. As extensively de-
scribed in excellent recent reviews [i.e., Refs. (112, 201)],
oxidative stress and ROS are largely responsible for the
neurodegeneration underlying diabetic neuropathy. Impor-
tantly, it has long been noted that the longer axons suffer the
most (which is probably to do with the metabolic challenges
associated with long axons).
NO and the Peripheral Somatosensory System
NO is a molecular mediator with diverse physiological
roles, including vasodilation, blood clotting, and nociception.
It is released from arteries, following mechanical stimuli or
from dural mast cells or nerve fibers, after inflammation,
contributing to pain (17). In the central and peripheral ner-
vous systems, NO displays many properties of a neuro-
transmitter (55). As a gasotransmitter, NO is diffusible across
membranes and its physiological effects are relatively short
lived, being oxidized to nitrite in the time frame of seconds
(110). NO-mediated signaling pathways include the activa-
tion of soluble guanylate cyclase (GC) and the cyclic gua-
nosine monophosphate (cGMP)/protein kinase G (PKG)
pathway (25), direct S-nitrosylation of protein thiols (addi-
tion of a nitrosyl ion NO - to generate a nitrosothiol, RS-
N = O) (95) and protein tyrosine nitration (addition of NO2 to
generate 3-nitrotyrosine) (16, 124). Each of these pathways
has been linked to pathology of one form or another and
diversion toward one of these pathways over another depends
on a multitude of factors in the system, including the presence
of transition metal complexes and redox status (195). With
such varied and wide-ranging effects, understanding the in-
dividual signaling pathways of NO is of extreme importance,
though relatively little is known about the molecular players
involved in these processes. NO has been implicated in mi-
graine, as it was reported to induce CGRP release from tri-
geminal afferents and CGRP levels are increased during a
migraine attack in humans (51, 58). In animal models, mi-
graines can be induced by NO donors and reduced with
CGRP antagonists (85, 210) or trigeminal denervation (210).
Trigeminal models show that NO increases the release of
CGRP from afferent fibers (113), which is not caused by
increases in CGRP mRNA (50) but which could be the result
of increased neuronal activity. An injection of NO donors
into the periphery is also painful and in rat paw causes hy-
peraemia via release of the vasodilatory CGRP from afferent
nerve fibers and up-regulation of prostaglandin production
(68). However, antinociceptive effects of NO have also been
suggested; see ‘‘K
atp
channels’’ section and also see (134) for
review.
The contribution of the individual NOS isoforms to in-
flammatory pain has been elucidated using isoform-specific
FIG. 4. Some isomerization and cleavage pathways of
protonated ONOO2. Nitrosative stress-associated path-
ways are indicated by the bold gray arrows.
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knockout mice. In mice deficient for nNOS, thermal hyper-
algesia, after an injection of complete Freund’s adjuvant
(CFA) was halved, mechanical hypersensitivity was absent
and CFA-induced increases in CGRP in DRG neurons were
reduced (21). These data suggest that nNOS plays a signifi-
cant role in sensitization of DRG neurons in inflammatory
pain. However, both iNOS and eNOS also contribute (21). In
DRG neurons, nNOS is expressed in early developmental
stages but is down-regulated with age (141, 194); both nNOS
and iNOS expression was reported to be up-regulated in DRG
after injury and inflammation (1, 60, 103, 104). Increased NO
synthesis in microglia and astrocytes in combination with the
properties that enable retrograde messenger activity has im-
plicated astrocytes and microglia as an external source of
pathogenic NO (179). Tissue inflammation thus likely leads
to increases in all three isoforms (nNOS, iNOS, and eNOS)
with vasodilation also increasing blood flow. Candidate
mediators of this effect are the P2 purinergic receptors, as the
P2 receptor antagonist pyridoxalphosphate-6-azophenyl-
2¢,4¢-disulphonic acid (PPADS) decreased face-rubbing ac-
tivity, NOS isoform expression in TG, and Fos expression in
the spinal trigeminal nucleus after a subcutaneous injection
of formalin (22).
An important aspect of sensory signaling by NO has re-
cently been identified in a study that focused on the pro-
duction of NO in the skin. TRPV3, a heat-sensitive ion
channel (169), is expressed in keratinocytes and on activa-
tion, induces NO production (115). This is an interesting
finding, as a number of the NO-modulated ion channels de-
scribed next are also expressed in skin cells, including Kv7
(146), TRPV1 (20), and TRPA1 (11) channels. Character-
ization of the precise details of the signaling pathways be-
tween the skin and the peripheral nervous system will provide
important contributions to our understanding of the role of
NO and ROS in sensory processing.
While our understanding of NO signaling in the peripheral
somatosensory system is still ‘‘work in progress,’’ roles of
NO in the CNS are much better understood; several recent
reviews cover these roles in processes as diverse as synaptic
plasticity (26, 64, 67), excitotoxicity (29), or neurodegen-
eration (179) and we direct readers interested in such effects
to these fine papers.
Physiological Relevance and Considerations
for Future Studies
The cellular functions of NO are complex and are highly
dependent on NO concentration. Broadly speaking, high
concentrations of NO are cytotoxic, while low concentrations
are cytoprotective. The complexities of measuring NO levels,
coupled with the fact that NO freely diffuses across mem-
branes in three-dimensional space, has made it difficult to
quantify the levels that accumulate during physiological
signalling in vivo. In fact, the use of the word ‘‘accumulate’’
may well be misleading in this context, as the presence of NO
as a signaling molecule is likely highly transient. This has led
to controversy and difficulties within the field, as astound-
ingly different physiological concentrations of NO have been
reported. We also need to consider the precise biological
context, with regard to both normal and pathological condi-
tions. In this way, levels measured via various means (using
electrode measurements, fluorescent probes, biosensors, and
selectivity of NO for GC-coupled NO receptors) and by
different groups have been reported from micromolar to pi-
comolar concentrations [reviewed in Hall and Garthwaite
(63)]. Certainly high concentrations of NO (potentially mi-
cromolar levels) can be released from inflammatory cells
after their activation, while levels released from endothelial
cells and neurons have been harder to measure accurately.
New findings suggest that picomolar concentrations of NO
can now be measured. In fact, it would appear that cells are
able to detect exceedingly low concentrations of NO, even
down to the picomolar level and even when the exposure is
brief (e.g., subsecond range) (214).
In addition, the function of NO is tightly coupled to oxi-
dative stress (see, e.g., Figs. 3 and 4), which makes it often
difficult to separate pure NO effects from these that are more
complex and require secondary mechanisms (e.g., ROS).
Thus, it is still unclear whether NO is able to bind Cys directly
at detectable levels or whether Cys nitrosylation requires an
additional oxidative mechanism to occur (54). Certainly the
biochemical tests (the ‘‘biotin switch assay’’ being the most
prominently used method) suggest that in many proteins,
cysteines are indeed nitrosylated but we will need to turn to
more precise techniques in the future to confirm this.
Many of the same considerations are also true for ROS,
whose precise concentrations in cells are difficult to measure,
and thus the biological relevance of many of the proposed
ROS mechanisms remains in question (181). Consequently,
tonic intracellular H2O2 concentrations in mammalian cells
were reported to vary in the range of 1–700 nM (181) and
H2O2 production can increase in ischemic brain by more than
10-fold (174), suggesting that an even greater range of con-
centrations may potentially be achievable in vivo. Clearly,
caution has to be executed when designing (and interpreting)
in vitro experiments with extracellular sources of highly
concentrated ROS or NO donors.
Regulation of Sensory Neuron Ion Channels
by ROS and NO
M channels
Among a plethora of ion channels expressed in somatosen-
sory (and particularly nociceptive) neurons, one subfamily is
gaining increased recognition for its central role in setting and
controlling background excitability, a subfamily of voltage-
gated K + channels called KCNQ (Kv7 or ‘‘M channels’’).
These K + channels conduct slow, non-inactivating ‘‘delayed-
rectifier’’ K + currents with a threshold for activation well
below - 60 mV (can be as low as - 80 mV) (70). These
properties enable some M channels to remain active at the
resting membrane potential of a sensory neuron (*- 60 mV)
(6, 91, 92, 160). Since M channels have strong outwardly
rectifying voltage dependence, their ‘‘background’’ activity
represents an ‘‘intrinsic voltage-clamp’’ mechanism that
controls the resting membrane potential, threshold for action
potential (AP) firing, and accommodation within trains of AP
[reviewed in Refs. (41, 49)]. Functional M channels are ex-
pressed in a variety of locations, including DRG neuron cell
bodies (80, 130, 228), nerve fibers (42, 80, 129, 154), dorsal
roots/central terminals (149), and nociceptive nerve endings
(129). As expected from their biophysical properties, M
channel activity strongly affects afferent fiber excitability
both in vitro and in vivo. Thus, M channel inhibition
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increases and M channel enhancers decrease action potential
firing in vitro [e.g., in cultured DRG neurons (91, 92, 98, 117,
130) or in skin-nerve preparations (129)]. Accordingly, a
hind paw injection of the M channel blocker XE991 in rats
induces moderate pain (94, 98), while peripheral injections
of M channel pharmacological enhancers, such as retigabine
and flupirtine, produce analgesic effects (98, 152).
In recent studies, we have found that four (Kv7.2–Kv7.5)
out of five M channel subunits possess a reactive cluster of
three successive cysteines in the S2–S3 linker (equivalent to
the positions C156, C157, and C158 in Kv7.4; Fig. 5), which
can be oxidized by physiologically relevant concentrations of
H2O2 (56, 91) or S-nitrosylated by NO donors (126). Oxi-
dation results in potent augmentation of M channel activity,
while nitrosylation results in channel inhibition (Fig. 5). With
regard to the H2O2 effect, we found that Kv7.2, 7.4, and 7.5
are potently augmented by extracellular H2O2 concentration
as low as 5 lM. Kv7.1 and Kv7.3 are largely insensitive to
H2O2 despite the fact that Kv7.3 (but not Kv7.1) possesses
the conserved triple-cysteine cluster which is necessary for
H2O2-induced augmentation of Kv7.2, Kv7.4, and Kv7.5
currents. The H2O2 induced a leftward shift in channel
voltage dependence and induced a prominent increase in
channel open probability (Po) at all voltages. Kv7 channels
have highly divergent tonic maximal Po values (that is Po at
saturating voltages under ‘‘control’’ conditions); thus, Kv7.2,
7.4 and Kv7.5 have a rather low Po in the range of 0.1–0.2,
whereas Kv7.3 has a maximal Po near unity (90, 165), which
is likely to explain the fact that H2O2 did not augment Kv7.3
current (as measured at saturating voltage of 0 mV). Kv7.1
differs from the rest of the family in that it has only one
cysteine residue within the ‘‘triple C’’ region; however, re-
constitution of the complete CCC sequence in Kv7.1 by
substitution of R86 and S87 with cysteines bestowed some
H2O2 sensitivity to this mutant, further supporting the con-
clusion that this triplet of cysteines mediates the redox
modulation of Kv7 channels. Interestingly, it seems that
oxidation of individual cysteines within the triple-C cluster
has a cumulative effect on M channel activity; thus, substi-
tution of all three cysteines was required to completely
abolish channel sensitivity to H2O2, while mutation of one or
even two cysteines resulted in partial reduction (but never a
complete loss) of H2O2 sensitivity (56). Cysteine residues can
be reversibly oxidized to cysteine sulfenic acid (Cys-SOH);
this derivative can be further (irreversibly) oxidized to
sulfinic acid (Cys-SO2H) and sulfonic acid (Cys-SO3H);
alternatively two juxtaposed Cys-SOH can react and form
intra- or intermolecular disulfide bonds with another protein
or low-molecular-weight thiol such as glutathione (128). We
were unable to detect the formation of intermolecular dis-
ulfide bonds specific to the triple cysteine region under non-
reducing PAGE. Given the fact that the H2O2 effect on Kv7
channel activity is completely reversed by the reducing agent
dithiothreitol (DTT) (56), while Cys-SO2H and Cys-SO3H
modifications cannot be reduced by DTT (135), our working
hypothesis is that cumulative oxidation of cysteines to cys-
teine sulfenic acids within the triple-C cluster mediates oxi-
dative augmentation of M-current (Fig. 5A). Interestingly, in
further experiments using patch-clamp electrophysiology and
the biotin-switch technique, we found that the same triplet of
cysteines can be directly S-nitrosylated in the presence of
the NO donor S-nitroso-N-acetyl-DL-penicillamine (SNAP),
an effect that leads to a marked decrease of M channel ac-
tivity (126). This finding raises an interesting possibility that
M channels, in fact, may serve a role of cellular sensors
conveying intracellular ROS and NO levels into the electrical
excitability of neuronal membranes. Indeed, small-diameter
DRG and TG neurons respond to NO donors with (i) M
channel inhibition; (ii) increased excitability; and (iii) in-
creased CGRP release (126). Conversely, H2O2 and endoge-
nous ROS mediate the opposite effect, that is, (i) enhancement
of M channel activity; (ii) moderate hyperpolarization in small
DRG neurons; and (iii) inhibition of CGRP release (91).
Moreover, these anti-excitatory effects were also observed in
response to endogenous O2
 - release from mitochondria
stimulated in small DRG neurons by substance P (91). Thus,
redox/NO-sensitivity of M channels may indeed play vital
regulatory and signaling roles within the somatosensory sys-
tem and particularly within nociceptive fibers. However, this
role of a membrane integrator of redox/NO status of the
FIG. 5. Modulation of M-type K1 channels by ROS
and NO. (A) Schematic showing the domain structure and
location of triplets of reactive cysteines within M channel
subunits Kv7.2–7.5. Putative chemical modifications of the
cysteines within the triplet are indicated with ‘‘SOH’’ de-
noting cysteine sulfenic acid formation and ‘‘SNO’’ denot-
ing cysteine S-nitrosylaton. (B) Modification by ROS
increases M-current, which leads to the inhibition of neu-
ronal excitability (green); whereas NO-mediated modifica-
tion suppresses M channel activity, leading to increased
excitability (red).
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cytosol is extremely complex. NO is generated by eNOS and
nNOS in the trigeminovascular system (142) and by immune
cells during an inflammatory response, via cytokine-induced
activation of iNOS (38), while many pathways involved in
inflammatory signaling also inhibit M-current (61, 74, 75, 93,
94, 98, 224, 225). Gq-protein-coupled receptors, such as
the bradykinin B2 receptor, evoke an intracellular signaling
cascade that stimulates cleavage of phosphatidylinositol 4,5-
bisphosphate (PIP2) into diacylglycerol (DAG) and inositol
1,4,5-trisphosphate (IP3), triggering Ca
2 + release from IP3-
sensitive stores. Both PIP2 depletion and Ca
2 + release inhibit
M-current directly. As previously shown, NO synthases are
calmodulin dependent and elevated Ca2 + triggers NO pro-
duction from nNOS by activating calmodulin (2); while NOS
activity is inhibited by PIP2 (218). In this way, Gq-PCR in-
flammatory signaling would be able to increase NO levels
by two means, the removal of PIP2-mediated inhibition of NOS
and increases in Ca2 + activating NOS. This suggests that in-
flammatory Gq-PCR signaling and NO may work in concert to
ensure robust inhibition of M-current. In addition to these ef-
fects, NO can react rapidly with endogenous O2
 - and form a
strong neurotoxic oxidant, ONOO - , a major cytotoxic agent
produced during inflammation, sepsis, and ischemia/reperfu-
sion (15, 95). Formation of ONOO - by O2
 - and scavenging
of NO leads to the inhibition of mitochondrial respiration and
SOD activity, potentially establishing a feed-forward loop for
ONOO - formation and oxidative modification of M channels
(although the direct effect of ONOO - on M channel activity
has not been demonstrated thus far). This provides for a po-
tential difference in the cellular effects of NO, depending on
redox state, by which ONOO- formation augments M-current,
decreasing excitability but NO inhibits M-current, increasing
excitability. As a gasotransmitter, NO and its effects are short
lived and highly regionally specific, features that underlie a
possibility for location- and temporal-specific regulation of ion
channels. Thus, at precise loci, the redox environment will
determine the ultimate effect of NO release on M-current.
KATP channels
ATP-sensitive K + channels (KATP) are heteromeric chan-
nels formed by Kir6.1 or Kir6.2 subunits of inward-rectifier
K + channels and regulatory sulfonylurea receptor subunits
SUR1 or SUR2 (65). Physiologically, KATP channels are in-
hibited by intracellular ATP and activated by cytosolic ATP
depletion, thus serving the role of cellular metabolic sensors.
KATP channels have been suggested to play a neuroprotective
role in parts of the CNS in some pathological conditions, such
as ischemia (216). In the peripheral nervous system, KATP
channels (i.e., Kir6.2, SUR1, and SUR2) are expressed in a
subpopulation of DRG neurons of various sizes (229). KATP
currents in small DRG neurons are relatively small, but KATP
channel enhancers (diazoxide and pinacidil) hyperpolarize
nociceptive neurons and reduce bradykinin-induced pain (48).
Similar to M channels, KATP channels are augmented by en-
dogenous H2O2, as has been shown in dorsal striatal neurons
(12), and the resulting hyperpolarization of neurons has been
suggested as a mechanism of neuroprotective silencing in
hypoxia (198). The molecular mechanism of the KATP channel
sensitivity to ROS remains to be established; thus far, it has
been reported that the effect is probably direct and is medi-
ated by decreasing channel sensitivity to ATP (71); SUR1-
containing KATP channels are more sensitive to H2O2 (147).
It is not yet tested whether ROS sensitivity of KATP channels
plays any role in sensory neurons.
KATP channels are also sensitive to NO; however, in
contrast to M channels, NO, similar to ROS, activate KATP
channels in DRG neurons (as shown using excised-patch
electrophysiology); the effect is possibly mediated via the
direct S-nitrosylation of the SUR1 subunit of the channel
complex (77). However, an indirect activation of KATP
channels in DRG neurons by NO acting via the classical NO/
sGC/cGMP/PKG pathway has also been suggested in other
studies (170, 171) (Fig. 6). After peripheral nerve injury, the
nociceptive effects of NO are exacerbated, potentially due to
inflammation and associated increases in neuronal excit-
ability. The NO donor SNAP caused activation of KATP
channels, resulting in decreased neuronal excitation of large
DRG neurons after axotomy (77). Peripheral injections of NO
donors showed antihyperalgesic effects in some studies (al-
though pro-algesic effects were also demonstrated in others
and these were suggested to be mediated by KATP channel
opening via the NO/sGC/cGMP/PKG pathway (156).
As per examples given earlier, it appears that peripheral
somatosensory actions of NO can be either pro-nociceptive or
antinociceptive depending on the experimental conditions
and models used [for review see Refs. (40, 134)]. For in-
stance, a dual action of locally applied NO donors on tactile
allodynia induced by surgical incision in rats has been noted
(136); lower concentrations of SNAP reduced allodynia in a
GC-dependent manner, while higher concentrations enhanced
allodynia, independently of GC. Since NO has opposing ef-
fects on M channels and KATP channels, it is conceivable that
at least some pro-algesic effects can be mediated by M channel
inhibition, while analgesic effects can potentially be mediated
by KATP activation. In such a scenario, the exact outcome of
the NO effect would depend on the relative expression and
activity of M channels and KATP channels in the affected
neurons and the spatial correlation of the NO release events
with the locality of these channels within the neuronal plasma
membrane. It should be noted that KATP channels appear to be
slightly more sensitive to NO as compared with M channels;
the activating effect of SNAP on KATP channels reached sat-
uration at 100 lM (77), while for M channels the SNAP IC50
has been determined at 370 lM (126).
BK channels
Large-conductance Ca2 + -activated K + channels (Slo1,
BK, and Maxi-K) are expressed in DRG neurons of various
FIG. 6. Putative mechanisms of regulation of KATP
channels by NO. NBD, nucleotide binding domain; NEM,
N-ethylmaleimide; DTT, dithiothreitol; SNAP, S-nitroso-N-
acetyl-DL-penicillamine; GC, guanylate cyclase; cGMP,
cyclic guanosine monophosphate; PKG, protein kinase G.
Based on the data from Refs. (77, 122, 134).
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sizes as demonstrated with correlative patch clamp analysis
and RT-PCR (89, 163); the auxiliary subunit b2 was sug-
gested to participate in the BK channel complex in DRG (89,
163). The major functions of BK channels in sensory neurons
were suggested to include shortening of the action potential,
acceleration of repolarization, and fast after-hyperpolarization
(89, 163). These effects may both limit neuronal excitability/
output or, somewhat paradoxically, increase it as fast repo-
larization and more prominent after hyperpolarization may
result in an increased firing rate due to improved recovery of
voltage-gated Na+ channels (VGNC) from the inactivation
(82). The BK channel protein contains multiple cysteine and
methionine residues that potentially can be oxidized to mod-
ulate channel function (i.e., human Slo1 protein AAB65837
has 29 cysteines and 30 methionines) and BK channels are
well established as O2 sensors, responsive to gasotransmitter
modulation (78, 157). The general mechanisms of redox
modulation of BK channels were recently reviewed in depth
in an excellent review (157); therefore, here, we only briefly
consider some key facts. The presence of multiple cysteines
and methionines within Slo1 proteins results in a complex
response to oxidizers and cysteine-modifying reagents. Thus,
heterologousely expressed Slo1 channels are inhibited by
H2O2 and activated by DTT (45), presumably via cysteine-
oxidation mechanisms. The application of various cysteine-
modifying agents such as 2-(trimethylammonium)ethyl
methanethiosulfonate (MTSET), (2-sulfonatoethyl)methane-
thiosulfonate (MTSES), or N-ethylmaleimide (NEM) to Slo1
changed channel voltage- and Ca2 + dependence of steady-
state activation. Moreover these agents, while acting on the
same cysteines, had different effects on channel function.
For instance, MTSET increased Slo1 K + conductance and
shifted voltage dependence to more negative voltages, while
MTSES and NEM had the opposite effects (226). There is
also evidence that methionine oxidation and cysteine oxida-
tion may have opposing effects on channel activity (191).
Thus, redox modulation of BK channels is incredibly com-
plex and the outcome of such modulation is likely to depend
on the nature of the redox changes and local environment.
The significance of redox modulation of BK channels for
sensory neurons has not yet been elucidated.
Literature on the regulation of BK channels by NO is more
coherent, as there is a broad agreement that in neurons and
smooth muscle cells, BK channel activity can be augmented
via the classical NO/sGC/cGMP/PKG pathway (10, 82, 102,
164, 217), by which the activation of PKG by cGMP leads to
phosphorylation of the Slo1 channel protein at three specific
PKG phosphorylation sites, an effect that results in en-
hancement of channel activity (86).
While redox/NO modulation of BK channels can be
complex, there is possibly a pattern for reciprocal effects;
however, in contrast to M channels, ROS, such as H2O2, are
rather inhibitory, while NO enhances channel activity. It
would be interesting to investigate how (and if ) the redox/NO
modulation of BK channels affects peripheral somatosensory
transmission.
A-type K + channels
Somatosensory neurons express robust A currents (IKA,
inactivating voltage-gated K + current) that can be further
pharmacologically and electrophysiologically separated into
two or three subtypes which are distinguishable by different
inactivation kinetics (i.e., slow- and fast-inactivating IKA)
and sensitivity to tetraethylammonium (TEA) (3, 52, 59, 111,
173, 219); see Du and Gamper (49) for review. The IKA with
slower inactivation kinetics is predominantly found in small-
diameter nociceptors that also express TTX-resistant Na +
channels and TRPV1 (59, 223). IKA is conducted by Kvs,
several members of which are expressed in sensory neurons.
Thus, the expression of several members of the Kv1.1
channel family has been reported with Kv1.1, Kv1.2, and
Kv1.4 being the most abundantly expressed subunits (79,
145, 204, 219). Kv1.1 and Kv1.2 are predominantly found in
non-nociceptive, large-diameter DRG neurons. In small-
diameter nociceptive DRG neurons, the predominant Kv1
a-subunit is Kv1.4 (145, 204), a rapidly inactivating A-type
K + channel (37). Inactivating subunits of Kv3 (Kv3.4) and
Kv4 (Kv4.3) channel families are also expressed in sen-
sory neurons and contribute to IKA, particularly in noci-
ceptors (32).
Several A-type forming Kv subunits have been found to be
sensitive to ROS. Thus, inactivation of Kv1.4 and Kv3.4 is
slowed by oxidation, an effect reversed by reducing agents
(155). Cysteine C13 was found to be responsible for this
effect in Kv1.4 (155) [a detailed discussion on the regulation
of Kv channel inactivation by ROS can be found in Sahoo
et al. (157)]. Interestingly, the modulation of native IKA by
ROS has been reported in small-diameter DRG neurons (69),
suggesting that the redox sensitivity of Kv channels may have
a physiological role in peripheral somatosensory processing.
Thus, the oxidizing agents DTBNP and chloramine-T re-
duced fast inactivation of IKA in cultured small DRG neurons,
while the reducing agent DTT reversed this effect (69). If the
fast inactivation of IKA being reduced by oxidation, the un-
derlying Kv channels would become less susceptible for
cumulative inactivation during repetitive firing, which, in
turn, may affect firing rate and thus modulate the sensitivity
of nociceptive fibers. It, however, should be noted that in the
study (69), the IKA has been pharmacologically isolated in
DRG neurons by the addition of 5 mM TEA to inhibit the
delayed-rectifier K + channel current. However, at this con-
centration, TEA would only partially block M channels; only
Kv7.2 is sensitive to TEA in a low millimolar range, while
other M channel subunits expressed in DRG, Kv7.3 and
Kv7.5 are poorly TEA insensitive (62, 166, 221). The clas-
sical M channel, which is a Kv7.2/Kv7.3 heteromer, has a
TEA IC50 in the range of 5 mM (62, 166, 208, 221) and, thus,
will only be 50% blocked at this concentration. M channels
have slow kinetics and as discussed earlier are potently
augmented by oxidizing agents [and these effects are re-
versed by DTT (56, 91, 92)]. Therefore, the increase in
steady-state K + current on application of oxidizing agents
that was interpreted as reduction of inactivation (69) is also
consistent with an increased contribution of M-current to the
total K + current recorded. Clearly, further research is needed
to elucidate the exact molecular mechanisms of sensory
neuron K + current modulation by redox signaling.
T-type Ca2 + channels
T-type Ca2 + channels (encoded by the CACNA1G, CAC-
NA1H, and CACNA1I genes, which code for Cav3.1–3.3
channel a-subunits, respectively) are expressed in a
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subpopulation of DRG neurons of various types [from small/
medium-diameter nociceptors to some large-diameter, me-
chanosensitive neurons (39, 73, 153)]. These channels differ
from other voltage-gated Ca2 + channels (VGCCs) in several
important features; thus, they are activated at voltages below
- 60 mV (hence, they are also termed ‘‘low-voltage activat-
ed’’ Ca2 + channels [LVA]); T-type channels activate and
inactivate rapidly and have a smaller single-channel con-
ductance than high-voltage-activated VGCCs (30, 72, 133).
In the CNS, T-type channels are responsible for pacemaker
activity and low threshold spikes; they also may display a
significant window current (i.e., they can be tonically active)
at membrane potentials close to the resting membrane po-
tential and consequently can contribute to tonic Ca2 + influx
(30, 72, 133). In DRG neurons, Cav3.2 is the predominantly
expressed T-type channel subunit (168, 189). It is hypothe-
sized that in sensory fibers, T-type channels can participate in
setting the threshold for action potential firing and control
burst firing (119, 121, 211). It has been shown that in noci-
ceptive neurons, T-type current amplitudes can be augmented
by reducing agents such as DTT or l-cysteine and inhibited
by the oxidizing agent 5,5¢-dithiobis-(2-nitrobenzoic acid)
(DTNB) (197). In accord with its role in nociception, plantar
injections of DTT or l-cysteine into rat hind paws induced
thermal and mechanical hyperalgesia (197). These effects
were prevented by the T-type inhibitor mibefradil; moreover,
a peripheral injection of DTNB had an anti-nociceptive ef-
fect. Currents mediated by Cav3.2 are also strongly inhibited
by ascorbate in a mechanism that is unique to Cav3.2. As-
corbate is best known for its ‘‘antioxidant’’ properties.
However, ascorbate can catalyze the formation of several
ROS, including OH, O2
 - , and H2O2 by reducing Fe
3 + and
Cu2 + to Fe2 + and Cu + and by reducing molecular oxygen
(ascorbate-metal ion catalyzed oxidation [MCO]) (172). It
has been suggested that ascorbate can inhibit Cav3.2 (but not
the other T-type a subunits) by an MCO of a unique metal-
binding histidine residue, His191 (in human Cav3.2) in the
extracellular S3–S4 linker of domain I (120). The same his-
tidine residue apparently mediates augmentation of Cav3.2
currents by l-cysteine (121). l-cysteine was shown to prevent
tonic channel inhibition by endogenous zinc ions.
Carbon monoxide (CO) is increasingly being recognized
as a potent intracellular second messenger or gasotransmitter
[for review see Peers and Steele (131)]. A recent study re-
ported CO-mediated inhibition of Cav3.2 in DRG neurons, an
effect which was based on a redox mechanism distinct from
that involving the MCO of His191 (23). CO is produced in
cells by the heme oxygenase (HO) enzyme, which degrades
heme and produces biliverdin, free iron (Fe2 + ), and CO.
Growing evidence suggests that HOs can modulate noci-
ception; thus, HO-1 is induced in DRG neurons in response to
heat stress (132) or axonal damage (107). Accordingly, local
endogenous CO has been suggested to suppress inflamma-
tory hyperalgesia in the carrageenan model of pain (178).
Moreover, the chemical induction of HO-1 inhibited the
nociceptive response to formalin, while the transcriptional
inhibition of HO-1 production prevented this effect (151).
Boycott et al. (23) have shown that heterologousely ex-
pressed Cav3.1, Cav3.2, and Cav3.3 as well as native T-type
current in cultured DRG neurons is potently inhibited by the
CO donor CORM-2, an effect that was significantly reversed
by DTT. CO sensitivity of Cav3.2 (but not the other two
subunits) was mediated by an extracellular redox-sensitive
site, which was also highly sensitive to thioredoxin (TR) but
was distinct from His191. It has been suggested that TR acts
as a tonic, endogenous regulator of Cav3.2 channels; while
HO-1-derived CO disrupts this regulation, causing channel
inhibition. Taken together, these studies emphasize the im-
portance of T-type channels and their redox sensitivity to
peripheral somatosensory (and particularly nociceptive)
transmission.
TRP channels
Transient receptor potential (TRP) channels are universal
cellular sensors that are capable of responding to versatile
external stimuli such as temperature, pH, and changes in the
chemical milieu. Several TRP channels are preferentially
expressed in peripheral somatosensory neurons where these
mediate neuronal responses to the environment. Probably the
best studied sensory TRP channels within peripheral sensory
nerves are TRPV1 and TRPA1 [for a review, see e.g., Vay
et al. (202)]. TRPV1 is a member of the vanilloid subfamily
of TRP channels; it is expressed in subpopulations of all the
major types of nociceptive neurons (nociceptive Ad fibers,
peptidergic and non-peptidergic C-fibers). TRPV1 is a ver-
satile sensor that is activated by a wide range of stimuli such
as capsaicin, noxious heat, protons (acidification), en-
docannabinoids, ethanol, camphor, allicin, 2-APB, lidocaine,
x-3 fatty acids, and many others. The mechanisms of TRPV1
activation and its role in thermosensation and pain have been
extensively reviewed [e.g., Refs. (31, 44, 202)]; therefore,
here, we will only consider mechanisms relevant to the topic
of this article. TRPV1 (together with several other TRP
channels, for example, TRPC1, TRPC4, TRPC5, TRPV3,
and TRPV4) is activated by NO in a process that is likely
mediated by direct S-nitrosylation of cysteines (222). Like-
wise, TRPV1 is also activated by H2O2. In TRPC5, the action
of these cysteine-modifying agents was localized to C553 and
C558 within the extracellular S5–S6 linker (Fig. 7A); TRPV1
also has two cysteines in this region (C616 and C621), ac-
cordingly it was suggested that TRPV1 is regulated by the
same mechanism as the substitution of these two residues
reduced sensitivity to H2O2 and the cysteine-modifying re-
agent 5-nitro-2-PDS (222). Surprisingly, the sensitization of
heat- and capsaicin sensitivity of TRPV1 by both oxidizing
(diamide, H2O2 and chloramine-T) and reducing (DTT and re-
duced glutathione) agents has also been reported (186, 205).
Interestingly, in the latter study, the effect of the reducing
agents was linked to the same extracellular cysteines C616
and C621 (with the additional C634 that was also considered
important for the effect in this study); while the sensitizing
effect of the oxidizing compounds was found to be dependent
on intracellularly facing residues. Chuang and Lin have
identified the C-terminal cysteines C772 and C783 as being
necessary for the sensitizing action of oxidizing agents (36).
TRPV1 can also be activated by pungent compounds from
onion and garlic, such as allicin (106). The action of allicin
has been localized to a single cysteine C157 within the
TRPV1 N-terminus (159). This is a physiologically relevant
mechanism, as it underlies the responses of sensory neurons
that express TRPV1 (and TRPA1, which is also sensitive to
allicin via a similar mechanism) to these pungent stimuli.
While the precise mechanics of redox/NO regulation of
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TRPV1 are still emerging, it is clear that the channel is very
sensitive to such modulation and that multiple mechanisms
exist. Since tissue damage and inflammation are linked to
ROS and RNS production, it is likely that redox/NO modu-
lation of TRPV1 has a prominent role in inflammatory pain
mechanisms.
TRPA1 is the only member of the ankyrin subfamily of
TRP channels in mammals; similar to TRPV1, TRPA1 is also
highly expressed in peripheral somatosensory fibers, partic-
ularly in those that are activated by both noxious cold and a
wide range of environmental irritants (13, 19, 182). Similar to
TRPV1, TRPA1 is a ‘‘promiscuous’’ sensor that is activated
by a variety of stimuli, including temperatures below 15C,
cinnamaldehyde, endocannabinoids, acrolein, allicin, icilin,
gingerol chlorine, ROS, nicotine, and many others [for re-
view see Refs. (14, 123, 202)]. Some of the compounds that
activate TRPV1 can also activate TRPA1; moreover, both
channels are often co-expressed in the same sensory neurons
and possibly interact physically (4, 158, 176). Similar to the
case of TRPV1, both NO donors (SNAP, NOR3) and ROS
(H2O2) activate TRPA1 (both the native channel in sensory
neurons and heterologously overexpressed TRPA1) (7, 18,
114, 161, 187). Again, similar to TRPV1, a common theme in
the action of ROS, NO, and irritants is multiple modifications
of channel cysteines. Thus, two groups have identified five
cysteines (all in the channel N-terminus) to be responsible for
TRPA1 activation by irritants but only one of them (C622 in
mouse TRPA1) was identified by both groups (66, 105).
Covalent modification of lysine 708 (in human TRPA1) by
isothiocyanates was also reported to contribute to the acti-
vation of TRPA1 (66). In another study, C421, C641, and
C665 of human TRPA1 (all within the N-terminus) were
found to be mostly responsible for channel TRPA1 activation
by NO donors and H2O2 (187); positions of the reactive
cysteines in the human TRPA1 N-terminus are indicated in
Figure 7B. Thus, while having similar functional outcomes,
the sensitivity of the TRPA1 channel to redox/NO modula-
tion may be underwritten by somewhat different structural
mechanisms as compared with TRPV1 in which both the
N-terminus and the pore region were implicated. Modulation
of TRPA1 via modification of reactive cysteines has obvious
physiological importance, as it underlies sensory responses to
airborne irritants (13, 18) and is likely to contribute to dis-
orders such as asthma (27) and chronic itch (97, 212).
Other channels
The number of sensory ion channels being identified as
NO- and ROS-regulated is growing rapidly, indicating the
importance of these signaling molecules in controlling ex-
citability and pain processing. In DRG neurons, acid-
sensing ion channels are potentiated by NO, and NO donors
increased the pain of acid injections into the skin in hu-
mans (28). Potentiation of VGNC by endogenous ROS in
small- and medium-sized DRG neurons has been recently
suggested, as VGNC current density decreased after ap-
plication of ROS scavengers (207). In addition, another
study reported that in vitro hyperglycemia produced both
increased ROS production and augmented VGNC currents
in cultured DRG neurons. These are, however, indirect ev-
idence and the sensitivity of VGNC to ROS needs to be
tested further. Peripheral sensory neurons use glutamate as
their main neurotransmitter; interestingly, DRG neurons
also abundantly express somatic N-methyl-d-aspartate
(NMDA) receptors (84), and there is evidence that there is
also extrasynaptic (i.e., somatic) glutamate release in DRG
(84). While the function of extrasynaptic glutamatergic
circuitry in DRG remains unknown, a recent report some-
what paradoxically demonstrated that DRG-specific ge-
netic deletion of the NR1 subunit of NMDA receptors in
mice resulted in DRG hyperexcitability and pain hyper-
sensitivity (127). NMDA receptors represent another ion
FIG. 7. Modulation of TRP channels by ROS and ni-
trosylation. (A) Model for TRP channel activation by NO
and reactive disulfides (based on TRPC5 and proposed to be
applicable to other NO-sensitive TRP channels, including
TRPV1). Adapted from Yoshida et al. (222) with permis-
sion. (B) Reactive cysteine residues (black circles) of hu-
man TRPA1; adapted from Takahashi and Mori (188) with
permission. TRP, transient receptor potential.
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channel type which is robustly modulated by NO and ROS
through mechanisms that are relatively well understood
[see Lipton et al. (96) for review]. Thus, six cysteine resi-
dues (Fig. 8) are involved in redox modulation of the
channel by oxidizing agents, such as DTNB, inhibiting
NMDA receptor current while reducing agents such as DTT
or dihydrolipoic acid increase channel activity (34, 35, 127,
184). Four of these six cysteines are located within NR1
subunit (C79, C308, C744, and C798), while the final pair is
in the NR2A subunit (C87 and C320). Five cysteines can be
directly S-nitrosylated: C744 and C798 of NR1, and C87,
C320, and C399 of NR2A (35). S-nitrosylation of all these
residues is inhibitory. Four residues (C744, C798 of NR1,
C87, and C320 of NR2A) are susceptible to both redox and
NO modulation (Fig. 8). While it is not yet clear whether
redox/NO modulation of NMDA receptors plays any role in
peripheral somatosensory transduction, the fact that genetic
deletion of NR1 specifically in peripheral somatosensory
neurons results in distinct pain hypersensitivity suggests
that this is likely to be the case.
Role for Lipids in Redox and NO Modulatory Pathways
When considering the regulation of channel proteins by
ROS and NO, the contribution of modifications to the lipid
membrane in which these channels are located should not be
overlooked. Many of the channels mentioned earlier display a
complex relationship not only with ROS and NO but also
with the molecular composition of the lipid bilayer. Oxida-
tive stress is the physiological state in which the formation of
ROS is favored and oxidative damage to a cell or tissue can
subsequently result. A large proportion of ROS are free
radicals that possess one unpaired electron, giving them a
high degree of reactivity. These species are produced during
normal cellular metabolism, particularly cellular respiration
that occurs in the mitochondria. Cells have a protective de-
fence system made up of enzymatic and non-enzymatic anti-
oxidants that decrease levels of ROS on their generation (see,
e.g., Fig. 2). Consequently cells exist in a state of equilibrium
with a fine balance between the production and sequestration
of ROS (47). Neurons have an inherent susceptibility to oxi-
dative stress for a number of reasons, including a deficiency in
antioxidants compared with other tissues of the body, meaning
a reduced ability to defend against ROS attack (9). In addition,
there is a greater production of ROS in neurons due to their
high rate of metabolic activity and a high content of transition
metals that are actively redistributed within the cell (46). Fi-
nally, the brain is composed of a high proportion of polyun-
saturated fatty acids (PUFA), which are susceptible to free
radical attack, causing changes in membrane permeability,
fluidity, and function (148).
Higher concentrations of cellular ROS arise due to dys-
regulation of cellular H2O2, NO, and
OH processing. The
increase in cellular ROS is a self-perpetuating mechanism, as
ROS damage lipids, which, in turn, also become radical
species. Lipid peroxidation occurs via a ROS mediated bis-
allylic reaction. The ROS removes a hydrogen atom from the
carbon adjacent to the double bond of PUFA, generating
species that are highly reactive electrophilic aldehydes (206).
This lipid peroxidation impairs the normal function of the cell
as lipid radicals and ROS are highly reactive and thus induce
lipid–lipid and lipid–protein cross-linking, which leads to an
increase in membrane rigidity, a decrease in membrane en-
zyme activity, as well as alterations to membrane perme-
ability and ion channel activity (8, 185, 220).
Phospholipids, sphingolipids, and sterols are known to
regulate a number of channels, including M channels (192),
inwardly rectifying Kir channels (150), TRPV1 (100, 138),
and TRPM8 (99). These lipid species are particularly sus-
ceptible to peroxidative damage due to higher levels of PU-
FAs, which are thought to be targeted by oxidative radicals in
disease (137). Lipid rafts are membrane microdomains that
are rich in cholesterol and sphingolipids, which further control
ion channel distribution and function. These lipid rafts control
the function of a number of ion channels in sensory neurons,
including M channels (125), Ca2 + -activated Cl- channel
ANO1/TMEM16A (76) purinergic P2 receptors (57), and
voltage-gated sodium channels (139). These papers show that
the manipulation of cholesterol levels within the membrane
has profound effects on ion channel function. Therefore, we
can consider lipids as playing an important role in signaling
by ROS and NO. However, due to the inherent difficulties in
manipulating levels of individual lipid species in sensory
neurons, their precise contribution to changes in ion channel
activity by ROS and RNS remains to be determined.
Concluding Remarks
The picture being assembled in the regulation of ion chan-
nels by ROS and RNS is one of extraordinary complexity.
FIG. 8. Cysteines involved in redox/NO modulation of
NMDA receptors. Residues involved in redox and NO
modulation are shown within the darker and lighter gray
circles, respectively; residues that were implicated in both
types of modulation are shown within the overlap of two
circles. Based on data from Refs. (34, 35, 127, 184).
NMDA, N-methyl-d-aspartate.
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These species are able to regulate channels by direct modi-
fication of amino acid residues, affecting signaling pathways
and/or altering redox state. ROS and RNS have inter-
connected modes of action and important physiological roles.
However, the exact mechanisms of ROS- and RNS-mediated
regulation of peripheral sensory neuron excitability are, at
best, fragmented and incomplete. We know that many ion
channels which are expressed in sensory fibers are sensitive to
ROS and RNS, and we also know that these reactive species
are being generated at increased levels in many pain states
(i.e., in inflammation, injury, etc.); nevertheless, a consistent
and inclusive picture is yet to be produced. Obviously, in-
tensive future research is needed; moreover, these future
studies will need to consider the system, as a whole, rather
than individual reactions and responses, in order to decipher
the most important effects. Evidently, a focus on ROS and
NO signaling in sensory processing is crucial not only for
understanding such processing (particularly in the disease
states where these transmitters are implicated) but also for
the development of future therapeutics.
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Abbreviations Used
ANO1¼ anoctamin, member 1
BK¼ big conductance K+
BH4¼ tetrahydrobiopterin
Cav, VGCC¼ voltage-gated Ca2+ channel
CFA¼ complete Freund’s adjuvant
cGMP¼ cyclic guanosine monophosphate
CGRP¼ calcitonin gene-related peptide
cNOS¼ constitutive NOS





CuSOD¼ copper superoxide dismutase
DAG¼ diacylglycerol














Kv¼ voltage-gated K+ channel
LVA¼ low-voltage activated Ca2+ channels










NOS¼ nitric oxide synthase
PIP2¼ phosphatidylinositol 4,5-bisphosphate
PKG¼ protein kinase G
PPADS¼ pyridoxalphosphate-6-azophenyl-2¢,
4¢-disulphonic acid





ROS¼ reactive oxygen species






TRP¼ transient receptor potential
TRPA1¼ transient receptor potential cation
channel, subfamily A, member 1
TRPC¼ transient receptor potential cation
channel, canonical
TRPM8¼ transient receptor potential cation
channel subfamily M member 8
TRPV1¼ transient receptor potential cation
channel, subfamily V, member 1
VGNC¼ voltage-gated Na+ channels
ZnSOD¼ zinc superoxide dismutase
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